event-trade登录编辑
Seeking AlphaCodex · 实盘不做把握 3/10
北京时间·🕒 发布 04:08:21时区推断·⟳ 抓取 04:08:23·⚡ 决策 08-04 04:31:38 +23m15s·84.6 天前

Inspire Medical上调2026年收入展望并给出全年EPS区间

Inspire Medical本条披露全年收入展望上调至8.35亿至8.75亿美元、调整后EPS 1.05至1.45美元。

📄 原文Seeking Alpha↗ 原文
Inspire Medical Systems Non-GAAP EPS of $0.14 beats by $0.39, revenue of $200.5M beats by $5.89M
Full Year 2026 Guidance The Company is raising its previously announced revenue outlook to be in the range of $835 mill…
不做 Inspire Medical Systems(INSP.US)
同一Inspire Medical二季度业绩材料已在08-03 20:08 UTC处理,当前重复转述,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-08-03 · 扩散 medium · price-in 风险 high ↗

消息传播链

  1. 2026-08-03 20:08 UTC其它已处理事件库非一手
    命中“Inspire Medical盘后提交二季度业绩8-K及投资者材料”,为同一具体催化。
  2. 2026-08-03 20:08 UTC财经媒体扩散Seeking Alpha非一手原文 ↗
    媒体转述全年2026指引数据。

关键理由

  • Inspire Medical本条披露全年收入展望上调至8.35亿至8.75亿美元、调整后EPS 1.05至1.45美元。
  • 已处理事件库在08-03 20:08 UTC命中同一公司二季度业绩8-K及投资者材料,当前为重复财报片段。

主要风险

  • 重复财报片段不应二次推卡。
工具调用 · 历史记录,结果未知(5 种)
  • search_processed_events · 结果未知
  • stock_quote · 结果未知
  • kb_search · 结果未知
  • search_case_library · 结果未知
  • validate_order · 结果未知

原文全文

展开原文 · 633 字
Full Year 2026 Guidance
The Company is raising its previously announced revenue outlook to be in the range of $835 million to $875 million. Additionally, the Company now expects annual adjusted operating margin to be in the range of 4% to 6%, diluted EPS to be in the range of $(0.42) to $0.17 and adjusted diluted EPS to be in the range of $1.05 to $1.45.
The Company’s outlook assumes an effective tax rate of approximately 95% to 100% and an adjusted effective tax rate of 30% to 35%, estimated weighted average diluted shares outstanding of approximately 29.4 million, and capital expenditures between $35 million to $40 million.

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。